Statement on Continued Efforts to Increase Availability of all Forms of Naloxone to Help Reduce Opioid Overdose Deaths – U.S. Food & Drug Administration – September 20, 2019

The FDA is working with other federal, state and local officials as well as health care providers, patients and communities across the country to increase availability of all forms of naloxone and combat the toll to communities, individuals and the economy resulting from opioid abuse and addiction. Read More.